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Abstract
 .  .The steady state transcript levels of the four hexokinase HK isozymes and four glucose transporter GLUT isoforms
were determined quantitatively by Northern analysis of RNA samples from rat tissues using synthetic fragments of the
RNAs encoding the HK isozymes and GLUT isoforms. Results showed that the levels of HK isozyme transcripts were low
 .in rat tissues, the level of that most highly expressed, the type I isozyme HKI , in the brain being 0.025% of the total
 .qpoly A RNA. A good correlation was found between the reported HK activities and the total amounts of transcripts
encoding all HK isozymes in various tissues, showing that the HK activities in tissues can be estimated from the total
amount of transcripts encoding HK isozymes. The proposed associated expressions of HK isozymes and GLUT isoforms in
particular tissues were confirmed at their transcript levels. The steady state transcript levels of type II HK and the type 1
GLUT isoform in the malignant tumor cell line AH130 were also determined quantitatively. q 1998 Elsevier Science B.V.
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1. Introduction
The uptake of glucose and its phosphorylation are
major processes in cellular glucose metabolism. In
mammalian cells, four isoforms of the transporter
 .GLUT1 to GLUT4 are known to facilitate the up-
take of glucose through the plasma membrane for
w x.recent reviews, see 1–5 . GLUT1 is expressed in a
variety of tissues, and so is thought to be responsible
Abbreviations: GLUT, glucose transporter; HK, hexokinase;
SSC, saline sodium citrate; RT-PCR, reverse transcription fol-
lowed by the polymerase chain reaction; BAT, brown adipose
tissue; WAT, white adipose tissue
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for ‘‘basal’’ glucose uptake in various cells. On the
other hand, the expressions of the other isoforms are
tissue specific: GLUT2 is predominantly expressed in
the liver, pancreatic b-cells, small intestine and kid-
ney, GLUT3 in the brain, and GLUT4 in muscles and
w xadipose tissue 1–5 .
The first step in the sequential reactions in glucose
 .metabolism is catalyzed by the four type I to IV
 .  w x.isozymes of hexokinase HK for reviews, see 6,7 .
 .As type I HK HKI is expressed predominantly in all
tissues except skeletal muscle and liver, it is consid-
ered as the ‘‘basic’’ HK, like GLUT1 of the GLUT
 .isoforms. Expression of the type II isozyme HKII is
highest in skeletal muscle and adipose tissue, that of
 .the type III isozyme HKIII at very low levels in all
 .tissues, and that of the type IV isozyme HKIV ,
0005-2736r98r$19.00 q 1998 Elsevier Science B.V. All rights reserved.
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 .usually known as glucokinase GK , at high levels in
the liver and pancreatic b-cells for reviews, see
w x.8–10 .
Based on these tissue specific distributions of the
GLUT isoforms and HK isozymes, their associated
w xexpressions have been postulated 9,10 : GLUT1 with
HKI, GLUT4 with HKII, and GLUT2 with HKIV.
However, these combinations were mainly concluded
from the qualitative transcript levels of the GLUT
isoforms and enzymic activities of the HK isozymes.
For understanding the mechanisms controlling energy
metabolism in various tissues, quantitative compari-
son of their transcript levels in various tissues is of
importance. Therefore, in this study, we analyzed the
steady state transcript levels of GLUT isoforms and
HK isozymes quantitatively using synthesized RNA
fragments. We also determined the transcript levels
of HKII and GLUT1 in the malignant tumor cell line
AH130.
2. Materials and methods
2.1. Materials
Isogen, used in purification of RNA, and an in
vitro RNA synthesis kit were purchased from Nippon
 .Gene Tokyo . Taq DNA polymerase, a BcaBEST
DNA labeling kit and Oligotex dT -super) were
 . w 32 x from TaKaRa Shuzo Kyoto . a- P dCTP specific
.radioactivity, 111 TBqrmmol was from Amersham
 .Bucks., U.K. . The multifunctional phagemids
pTZ18R and pTZ19R were obtained from Toyobo
 .  .Osaka and from Riken DNA Bank Wako , respec-
tively.
2.2. Construction of plasmids and preparation of
cDNA probes
All cDNA fragments except that of HKI were
w xprepared by RT-PCR as described previously 11,12
using first strand cDNAs prepared by reverse tran-
scription of mRNA as templates. The cDNA frag-
ments of GLUT isoforms with nucleotide sequences
w x w x414–929 for GLUT1 13 , 507–951 for GLUT2 14 ,
w x278–771 for GLUT3 15 and 242–799 for GLUT4
w x16 and those of HK isozymes with nucleotide se-
w xquences of 1615–2133 for type II 17 , 2250–2677
w x w xfor type III 18 and 116–696 for type IV 19 were
amplified. A cDNA clone of rat HKI was obtained
from a cDNA library of rat heart Clontech, code
.RL1006b . The inserted cDNA fragment of HKI was
subcloned into pUC19 vector using restriction sites of
EcoRI that were added artificially during preparation
of the library. From this plasmid, a cDNA fragment
of about 510 bp corresponding to nucleotides 937–
w x1452 20 , prepared by digestion with EcoRI and
NcoI, was used for construction of the expression
vector. These cDNA fragments were subcloned into
the multifunctional phagemid pTZ18R or pTZ19R,
and after confirmation of their nucleotide sequences,
the plasmids obtained were digested with the restric-
tion endonucleases at the multicloning sites. The
inserted cDNA fragments were gel-purified and used
as probes in Northern blotting. As we used different
regions of the entire cDNAs encoding GLUT iso-
forms and HK isozymes as probes, the cross-hybridi-
zations between probes and RNA samples could not
be examined by Northern blot analysis. However, on
use of high stringency hybridization conditions, the
degrees of cross-hybridizations of all probes used in
this study were estimated to be less than 5% by
 .Southern blot analysis data not shown .
( )q2.3. Preparations poly A RNA samples from rat
˝arious tissues
RNA samples of various tissues were obtained
from 4-week old male Wistar rats fed on standard
laboratory chow with water ad libitum at 248C. Tis-
sues from five rats were pooled and total RNAs were
purified with Isogen by the method recommended by
the supplier, which was essentially based on the
w x  .qreport of Chomczynski and Sacchi 21 . Poly A
RNA was purified from total RNA using oligotex dT
-super) .
2.4. Preparation of synthetic RNA fragments
Fragments of the RNAs encoding GLUT isoforms
and HK isozymes were prepared as follows. First, for
obtaining double stranded linear DNA, the expression
vectors prepared as described above were digested at
the 3X-terminus of the inserted cDNA fragment and
digested plasmids were precipitated with ethanol.
With 1.0 mg samples of these linearized DNAs as
templates, the RNA fragments encoding GLUT iso-
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forms and HK isozymes were transcribed using T7
RNA polymerase. After complete digestion of tem-
plate DNA with DNaseI, synthesized RNA fragments
were purified by phenolrchloroform extraction and
then repeated ethanol precipitation. The concentra-
tions of RNA samples were determined spectoropho-
tometrically in a Shimadzu spectrophotometer, model
UV-160.
2.5. Northern blotting and quantitati˝e determination
of transcript le˝els
Northern blotting was carried out essentially as
w xdescribed previously 22,23 . Briefly, RNA was sub-
jected to electrophoresis in 1.0% agarose containing
formaldehyde, transferred to a nitrocellulose mem-
brane, and hybridized by the standard procedure.
Unless otherwise noted, samples of 1.0 mg of
 .qpoly A RNA obtained from various normal tissues
of Wistar rats and 10–100 pg of synthesized RNA
fragments were used for analyses. After hybridization
with probes, the membranes were washed three times
 .with 2=saline sodium citrate SSC containing 0.1%
SDS at room temperature for 10 min and twice with
1=SSC containing 0.1% SDS at 608C for 30 min
each time and exposed to X-ray film with an intensi-
fying screen at y808C. The amount of each tran-
script was determined from its intensity in the auto-
radiogram with an ATTO image analyzer model AE-
6900 connected to a Macintosh model Quadra 650.
The amount of each transcript was normalized based
on the intensity of the hybridization signal observed
with the corresponding synthesized RNA fragment.
For staining of the transferred RNA, the membrane
was first soaked in 5% acetic acid for 15 min, then
immersed in solution containing 0.04% methylene
 .blue and 500 mM sodium acetate pH 5.2 for 10 min
and washed with water for 10 min.
3. Results
3.1. Purity of synthesized RNA samples
For quantitative evaluation of transcript levels, it is
important to determine the exact concentrations of
synthesized RNA samples and their high purities.
Contaminating free nucleotides in the RNA samples
Fig. 1. Denaturation agarose gel electrophoresis of synthesized
RNA samples of HK isozymes and GLUT isoforms. After syn-
thesis of RNAs, template DNAs were completely digested with
DNaseI. Then after elimination of the DNaseI by phenolrchloro-
form extraction, RNA samples were purified by repeated ethanol
precipitation. For confirmation of their purities and concentra-
 .tions, a fixed amount of each RNA sample 2.5mg was sub-
jected to electrophoresis in denaturing agarose gel. The RNA
samples were transferred to a nitrocellulose membrane and stained
by methylene blue. I to IV and 1–4 represent RNA samples of
HKI to HKIV and GLUT1 to GLUT4, respectively. The panel
labeled ‘‘DNA’’ shows results on electrophoresis of the cDNA
fragments used as probes in non-denaturing agarose gel.
used as substrates in RNA synthesis would increase
the ‘‘apparent’’ concentration of RNA samples. Thus,
we first purified synthesized RNA samples by re-
peated ethanol precipitation to eliminate contaminat-
ing free nucleotides completely. The extent of elimi-
nation of free nucleotides from the synthesized RNA
samples was examined by measuring the optical ab-
sorbance of the filtrate obtained by centrifugation of
RNA samples in Ultrafree C3-LGS Millipore, cut-off
.M.W.s10 000 at 4500=g for 20 min and was
concluded to be negligible in all RNA samples data
.not shown . Then, after determination of the concen-
trations of synthesized RNA samples from their ab-
sorbances, we further examined the purities and
amounts of RNA by denaturing agarose gel elec-
trophoresis. As shown in Fig. 1, results showed that
all the synthesized RNA samples gave a single band
of the same intensity at the expected site of migra-
tion. Therefore, their purities were concluded to be
high enough for further quantitative analyses.
3.2. Steady state transcript le˝els of HK isozymes in
rat tissues
Next, we analyzed the steady state transcript levels
of the four HK isozymes in rat normal tissues. For
 .qthis, samples of 1.0 mg of poly A RNA obtained
from rat brain, heart, kidney, liver, skeletal muscle,
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and white and brown adipose tissues WAT and
.BAT were subjected to electrophoresis and trans-
ferred on nitrocellulose membranes. Four membranes
with each of these samples prepared in this way were
used for hybridization with probes. As shown in Fig.
2, the transcript of HKI was observed in all tissues
except liver; the signal was strongest in the brain, and
the intensities in the heart, kidney and WAT were
almost the same, while those in skeletal muscle and
BAT were very weak. The signal of HKII was weak
in heart, skeletal muscle and adipose tissues. HKIII
gave no significant signal except a weak one in brain.
Expression of HKIV was only observed in the liver.
Fig. 2. Steady state transcript levels of the four HK isozymes in
 .qvarious rat tissues. Samples of 1mg of poly A RNA obtained
from various tissues were subjected to denaturing agarose gel
electrophoresis, transferred to nitrocellulose membranes and hy-
bridized with probes. I to IV show results for synthesized RNA
samples encoding HKI to HKIV, respectively.
3.3. Quantitati˝e determinations of the steady state
transcript le˝els of HK isozymes
In general, the steady state transcript levels of
particular proteins in various tissues can be compared
by the intensities of their hybridization bands, as
described above. However, it is difficult to compare
the amounts of the transcripts of different isoforms or
isozymes exactly due to the different specific radioac-
tivities and the affinities of the probes with tran-
scripts. Therefore, we measured the intensities of
hybridization bands with known amounts of synthe-
sized RNA fragments used as standards. As the steady
state transcript levels of these four HK isozymes
were markedly different in various tissues, we used
various amounts of RNA fragments of the four
isozymes to determine the amount of each transcript
exactly; 100 pg for HKI, 20 pg for HKII, 10 pg for
HKIII, and 20 pg for HKIV. As the hybridization
intensity of the synthesized RNA fragment of HKII
used as external standard was not different from that
 .qin the presence of poly A RNAs of WAT, it was
concluded that presence of irrelevant RNAs did not
cause any changes in the hybridization intensities of
synthesized RNA fragments. In addition, we exam-
 .qined the purity of poly A RNA from the steady
state transcript levels of b-actin in these RNA sam-
ples. Results showed that the transcript levels of
b-actin were not markedly different in RNA samples
 .from various tissues data not shown . Therefore, the
transcript levels of these HK isozymes in different
tissues could be determined quantitatively based on
the assumption that the probes hybridize with the
synthesized RNA fragments and transcripts in various
tissues equally and gave the same signal intensity.
Table 1 shows normalized values for the steady
state transcript levels of HK isozymes in various
tissues. HKI, the most abundantly expressed HK
isozyme, was found in the brain at a level of
 .q0.382 fmolrmg of poly A RNA. Of the four
isozymes, the level of HKIII was the lowest, its
 .qhighest level being only 0.006 fmolrmg of poly A
in the brain. Assuming that the average length of
transcripts was 2.0 kb, the total amount of transcripts
 .qin 1.0 mg of poly A RNA was calculated to be
1.52 pmol. Therefore, even in the brain, the amount
of transcripts encoding HKI was estimated to be only
 .q0.025% of the total poly A RNA, indicating a very
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Table 1
Amounts of transcripts encoding the four isozymes of hexokinase in normal rat tissues
 .Tissue HKI HKII HKIII HKIV Total relative amount in %
 .Brain 0.382 0.010 0.006 ND 0.398 100
 .Heart 0.130 0.074 ND ND 0.204 51.3
 .Kidney 0.079 ND ND ND 0.079 19.8
 .Liver ND ND ND 0.058 0.058 14.6
 .Muscle 0.009 0.112 ND ND 0.121 30.4
 .WAT 0.101 0.170 ND ND 0.271 68.1
 .BAT 0.007 0.156 ND ND 0.163 41.0
 .qValues are shown in fmolrmg poly A RNA. Numbers in parentheses in the column labeled ‘‘total’’ represent the sum of each
transcript relative to that in brain. WAT and BAT: white adipose tissue and brown adipose tissue, respectively. ND: no hybridized band,
or too low signal intensity to be analyzed.
low level of transcripts of HK isozymes. The total
amounts of the transcripts encoding these HK
isozymes in various tissues were determined from the
sum of amounts of the transcripts of all the HK
isozymes. Results indicated that HKI and HKII are
the major determinants of the steady state transcript
level of the HK isozymes.
3.4. Quantitati˝e analysis of steady state transcript
le˝els of GLUT isoforms in ˝arious tissues
Next, we determined the amounts of the transcripts
encoding the four GLUT isoforms in RNA samples
obtained from various rat tissues in the same way as
for HK isozymes. As shown in Fig. 3, the tissue
distributions of these four GLUT isoforms were es-
wsentially the same as those reported previously 13–
x16,24–26 . For quantification of the transcript levels,
Northern blot analysis was performed with fixed
amounts of synthesized RNA fragments; 50 pg for
GLUT1, 100 pg for GLUT2, 20 pg for GLUT3 and
100 pg for GLUT4. From the hybridization intensities
of these RNA fragments, the amounts of transcripts
were determined quantitatively as summarized in
Table 2.
The transcribed levels of HK isozymes in various
tissues were markedly different, but those of the
GLUT isoforms were less, the maximum difference
being about 5-fold between the highest level of
  .q.GLUT4 in muscle 0.699 fmolrmg of poly A and
the lowest level of GLUT3 in the brain
  .q .0.139 fmolrmg of poly A RNA . In addition, the
results in Tables 1 and 2 showed the specific associa-
tion of the expressions of certain HK isozymes and
w xGLUT isoforms, as suggested previously 9,10 : HKI
with GLUT1, HKII with GLUT4 and HKIV with
GLUT2.
Fig. 3. Steady state transcript levels of the four GLUT isoforms
 .qin various rat tissues. Samples of 1mg of poly A RNA from
the indicated tissues were analyzed as described in the legend of
Fig. 2. Results for synthetic RNA samples encoding GLUT1 to
GLUT4 are shown in columns 1–4.
( )Y. Shinohara et al.rBiochimica et Biophysica Acta 1368 1998 129–136134
Table 2
Amounts of transcripts encoding the four GLUT isoforms in normal rat tissues
 .Tissue GLUT1 GLUT2 GLUT3 GLUT4 Total relative amount in %
 .Brain 0.297 ND 0.139 ND 0.436 100
 .Heart 0.019 ND ND 0.288 0.307 70.4
 .Kidney 0.076 ND ND 0.018 0.094 21.6
 .Liver ND 0.616 ND ND 0.616 141.3
 .Muscle 0.011 ND ND 0.699 0.710 162.8
 .WAT 0.090 ND 0.045 0.464 0.599 137.4
 .BAT ND ND ND 0.239 0.239 54.8
 .qValues are shown in fmolrmg poly A RNA. For details, see legend to Table 1.
3.5. Quantitati˝e analysis of steady state transcript
le˝els of GLUT1 and HKII in the malignant tumor
cell line AH130
We found previously that the steady state tran-
script level of HKII was specifically and remarkably
elevated in a synchronized manner with that of
GLUT1, in rapidly growing poorly differentiated ma-
w xlignant tumor cell lines such as rat AH130 12,23 .
Therefore, we next determined their absolute amounts
in AH130 cells by the method described above. The
amounts of the transcripts encoding HKII and GLUT1
expressed in AH130 cells were determined to be 2.5
 .qand 18.5 fmolrmg of poly A RNA, respectively.
These values are significantly greater than those ob-
served in normal tissues. As described above, the
highest transcript level of HKII was observed in
  .qwhite adipose tissue 0.170 fmolrmg of poly A
.RNA and that of GLUT1 in the brain
  .q .0.297 fmolrmg of poly A RNA . Namely, the
transcript levels of HKII and GLUT1 in AH130 cells
were approximately 15 and 62 times those in normal
tissues, respectively, corresponding to about 0.16%
 .qand 1.22% of the total poly A RNA species, re-
spectively.
4. Discussion
The transcript levels of particular proteins have
usually been compared by northern blot analysis us-
ing the same amounts of mRNAs. However, this is
not possible for quantitative determination of the
transcript levels of different mRNA species due to
the differences in the specific radio activities and
affinities of the probes. For quantitative determina-
tion of the transcript levels of proteins in various
tissues by Northern analysis, the intensities of hy-
bridization bands of mRNA samples with probes
must be normalized by the hybridization intensities
with exact amounts of synthesized RNA fragments.
By this procedure, the amount of a steady state
transcript encoding certain protein can be determined
exactly and compared with those of other proteins.
To our knowledge, this method was first carried out
w xby Stepien et al. 27 for determination of the tran-
script levels of three isoforms of the human mito-
 .chondrial adenine nucleotide translocator ANT1-3
in various tissues.
In this study, based on the method of Stepien et al.
w x27 , we determined the ‘‘absolute’’ amounts of the
HK isozymes and GLUT isoforms transcribed. For
this, we first synthesized RNAs of HK isozymes and
GLUT isoforms and determined their concentrations
exactly. Then, we determined their steady state tran-
script levels quantitatively in normal rat tissues and
the transcript levels of HKII and GLUT1 in the
malignant tumor cell line AH130. Results showed
that the transcript level of HKI in the kidney was as
 .q low as 0.0052% of the total poly A RNA Table 1,
 .q  ..0.079 fmolrmg of poly A RNA s1.52 pmol .
This value was in accordance with the results of
w xcDNA screening. Namely, Nishi et al. 29 reported
that on molecular cloning of cDNA clones encoding
HKI from a cDNA library of human kidney, 79
clones of 1=106 phages gave positive signal in the
first screening. This finding indicates that the amount
of HKI mRNA is 0.0079% of the total mRNA.
Similarly, from the yield of glucokinase from the
liver, the content of glucokinase in total liver proteins
was estimated to be as low as 0.005% by Andreone et
w xal. 19 . The present study indicated a similar value of
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 .0.0038% Table 1 . Thus, the results of the present
study are in accord with reported results. In this
study, we expressed the amount of a particular mRNA
 .qrelative to total poly A RNAs in the tissue cells.
 .qWhen the total amount of poly A RNAs in cells
changes markedly, description of the amount of tran-
script relative to the total amount of cellular DNA
might be useful.
The total amounts of transcripts encoding the four
HK isozymes in various tissues were determined
from the sums of the amounts of each transcript as
shown in Table 1. The relative transcript levels in
 .various tissues were in the order, brain 100 , white
 .  .adipose tissue 68 , heart 51 , brown adipose tissue
 .  .  .  .41 , skeletal muscle 30 , kidney 20 and liver 15 .
It is interesting that the same order was observed in
the HK activity in various tissues except skeletal
muscle, although the specific enzyme activities of
HK isozymes were different, being in the order: brain
 .  .  .  .100 , heart 62 , kidney 49 , liver 15 and skeletal
 . w xmuscle 10 30 . Therefore, the sum of the amounts
of transcripts could be a useful parameter of the total
HK activities in various tissues. The exceptional low
HK activity in skeletal muscle from that expected by
the steady state transcript level could be because
expression of the most abundant type II HK in skele-
tal muscle is known to depend greatly on the contrac-
 . w xtile activity more than 30-fold 31 . Therefore, the
activity and transcript level of HKII in skeletal mus-
cle may vary remarkably in different samples.
We confirmed in this study that a certain HK
isozyme is expressed in association with a particular
GLUT isoform in various tissues: HKI with GLUT1,
 .HKII with GLUT4, and HKIV GK with GLUT2
w x9,10 . Therefore, the expressions of these HK
isozymes and GLUT isoforms could be regulated by
the same mechanisms. The molecular mechanisms of
the transcriptional regulations of GLUT isoforms and
HK isozymes in various tissues has been studied
w xextensively 8–10,32,33 , but it is still unknown
whether the expressions of HK isozymes in a particu-
lar tissue are regulated by the same mechanism as
those of the GLUT isoforms. To understand the
mechanisms regulating energy metabolism in various
tissues, it is important to examine how the associated
expressions of HK isozymes and GLUT isoforms in
tissues are regulated.
According to the ‘‘general association’’ concept
w x9,10 , expression of HKI is associated with that of
GLUT1 in normal tissues. Recently, we found a
novel association of HKII with GLUT1 in various
malignant tumor cells submitted for publication and
w x.also Ref. 12 . This finding was confirmed by quanti-
tative determinations of the transcript levels of HKII
and GLUT1 in AH130 cells, which showed that the
transcriptional regulations of HKII and GLUT1 in
malignant tumor cells are different from those in
normal tissues. Recently, two enhancer elements that
are responsive to serum, growth factor and oncogenes
were found in the gene encoding the GLUT1 isoform
w x33 . The gene encoding HKII has been studied ex-
w xtensively 11,12,28,34–40 , but the mechanism of its
transcriptional regulation during carcinogenesis is not
yet understood. Studies on the molecular mechanism
of its transcriptional regulation in relation to that of
the GLUT1 gene in tumor cells are in progress.
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